In terms of inhibiting the ALDH1A3 isoform specifically, disulfiram has minimal ALDH1A3 targeting activity in breast cancer cells [61] and inhibited glioblastoma stem cells independent of effects on ALDH1A3 [114]. Here, ALDH1A3 is linked to breast cancer.